ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Soliris (Eculizumab) Market Research Report 2026
Published Date: 2026-03-03
|
Report Code: QYRE-Auto-9C2608
Home | Market Reports | Health| Health Conditions
Global Soliris Eculizumab Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Soliris (Eculizumab) Market Research Report 2026

Code: QYRE-Auto-9C2608
Report
2026-03-03
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alexion

Soliris (Eculizumab) Market

The global Soliris (Eculizumab) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
In Asia-Pacific, Japan is the largest Soliris (Eculizumab) market with about 32% market share. China is follower, accounting for about 25% market share.The key manufacturers are Alexion etc.
This report delivers a comprehensive overview of the global Soliris (Eculizumab) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Soliris (Eculizumab). The Soliris (Eculizumab) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Soliris (Eculizumab) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Soliris (Eculizumab) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Soliris (Eculizumab) Market Report

Report Metric Details
Report Name Soliris (Eculizumab) Market
Segment by Type
  • Plasma Exchange
  • Plasma Infusion
Segment by Application
  • PNH
  • aHUS
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alexion
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Soliris (Eculizumab) companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

What is the Soliris (Eculizumab) Market share by region?

Ans: China is follower, accounting for about 25% market share.

Who are the main players in the Soliris (Eculizumab) Market report?

Ans: The main players in the Soliris (Eculizumab) Market are Alexion

What are the Application segmentation covered in the Soliris (Eculizumab) Market report?

Ans: The Applications covered in the Soliris (Eculizumab) Market report are PNH, aHUS, Others

What are the Type segmentation covered in the Soliris (Eculizumab) Market report?

Ans: The Types covered in the Soliris (Eculizumab) Market report are Plasma Exchange, Plasma Infusion

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soliris (Eculizumab) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Plasma Exchange
1.2.3 Plasma Infusion
1.3 Market by Application
1.3.1 Global Soliris (Eculizumab) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 PNH
1.3.3 aHUS
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Soliris (Eculizumab) Market Perspective (2021–2032)
2.2 Global Soliris (Eculizumab) Growth Trends by Region
2.2.1 Global Soliris (Eculizumab) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Soliris (Eculizumab) Historic Market Size by Region (2021–2026)
2.2.3 Soliris (Eculizumab) Forecasted Market Size by Region (2027–2032)
2.3 Soliris (Eculizumab) Market Dynamics
2.3.1 Soliris (Eculizumab) Industry Trends
2.3.2 Soliris (Eculizumab) Market Drivers
2.3.3 Soliris (Eculizumab) Market Challenges
2.3.4 Soliris (Eculizumab) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Soliris (Eculizumab) Players by Revenue
3.1.1 Global Top Soliris (Eculizumab) Players by Revenue (2021–2026)
3.1.2 Global Soliris (Eculizumab) Revenue Market Share by Players (2021–2026)
3.2 Global Top Soliris (Eculizumab) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Soliris (Eculizumab) Revenue
3.4 Global Soliris (Eculizumab) Market Concentration Ratio
3.4.1 Global Soliris (Eculizumab) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soliris (Eculizumab) Revenue in 2025
3.5 Global Key Players of Soliris (Eculizumab) Head Offices and Areas Served
3.6 Global Key Players of Soliris (Eculizumab), Products and Applications
3.7 Global Key Players of Soliris (Eculizumab), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Soliris (Eculizumab) Breakdown Data by Type
4.1 Global Soliris (Eculizumab) Historic Market Size by Type (2021–2026)
4.2 Global Soliris (Eculizumab) Forecasted Market Size by Type (2027–2032)
5 Soliris (Eculizumab) Breakdown Data by Application
5.1 Global Soliris (Eculizumab) Historic Market Size by Application (2021–2026)
5.2 Global Soliris (Eculizumab) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Soliris (Eculizumab) Market Size (2021–2032)
6.2 North America Soliris (Eculizumab) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Soliris (Eculizumab) Market Size by Country (2021–2026)
6.4 North America Soliris (Eculizumab) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Soliris (Eculizumab) Market Size (2021–2032)
7.2 Europe Soliris (Eculizumab) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Soliris (Eculizumab) Market Size by Country (2021–2026)
7.4 Europe Soliris (Eculizumab) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Soliris (Eculizumab) Market Size (2021–2032)
8.2 Asia-Pacific Soliris (Eculizumab) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Soliris (Eculizumab) Market Size by Region (2021–2026)
8.4 Asia-Pacific Soliris (Eculizumab) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Soliris (Eculizumab) Market Size (2021–2032)
9.2 Latin America Soliris (Eculizumab) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Soliris (Eculizumab) Market Size by Country (2021–2026)
9.4 Latin America Soliris (Eculizumab) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Soliris (Eculizumab) Market Size (2021–2032)
10.2 Middle East & Africa Soliris (Eculizumab) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Soliris (Eculizumab) Market Size by Country (2021–2026)
10.4 Middle East & Africa Soliris (Eculizumab) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alexion
11.1.1 Alexion Company Details
11.1.2 Alexion Business Overview
11.1.3 Alexion Soliris (Eculizumab) Introduction
11.1.4 Alexion Revenue in Soliris (Eculizumab) Business (2021–2026)
11.1.5 Alexion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Alexion
List of Tables
 Table 1. Global Soliris (Eculizumab) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Plasma Exchange
 Table 3. Key Players of Plasma Infusion
 Table 4. Global Soliris (Eculizumab) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Soliris (Eculizumab) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Soliris (Eculizumab) Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Soliris (Eculizumab) Market Share by Region (2021–2026)
 Table 8. Global Soliris (Eculizumab) Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Soliris (Eculizumab) Market Share by Region (2027–2032)
 Table 10. Soliris (Eculizumab) Market Trends
 Table 11. Soliris (Eculizumab) Market Drivers
 Table 12. Soliris (Eculizumab) Market Challenges
 Table 13. Soliris (Eculizumab) Market Restraints
 Table 14. Global Soliris (Eculizumab) Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Soliris (Eculizumab) Market Share by Players (2021–2026)
 Table 16. Global Top Soliris (Eculizumab) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Soliris (Eculizumab) Revenue, 2025
 Table 17. Ranking of Global Top Soliris (Eculizumab) Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Soliris (Eculizumab) Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Soliris (Eculizumab), Headquarters and Area Served
 Table 20. Global Key Players of Soliris (Eculizumab), Products and Applications
 Table 21. Global Key Players of Soliris (Eculizumab), Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Soliris (Eculizumab) Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Soliris (Eculizumab) Revenue Market Share by Type (2021–2026)
 Table 25. Global Soliris (Eculizumab) Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Soliris (Eculizumab) Revenue Market Share by Type (2027–2032)
 Table 27. Global Soliris (Eculizumab) Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Soliris (Eculizumab) Revenue Market Share by Application (2021–2026)
 Table 29. Global Soliris (Eculizumab) Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Soliris (Eculizumab) Revenue Market Share by Application (2027–2032)
 Table 31. North America Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Soliris (Eculizumab) Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Soliris (Eculizumab) Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Soliris (Eculizumab) Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Soliris (Eculizumab) Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Soliris (Eculizumab) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Soliris (Eculizumab) Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Soliris (Eculizumab) Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Soliris (Eculizumab) Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Soliris (Eculizumab) Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Soliris (Eculizumab) Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Soliris (Eculizumab) Market Size by Country (US$ Million), 2027–2032
 Table 46. Alexion Company Details
 Table 47. Alexion Business Overview
 Table 48. Alexion Soliris (Eculizumab) Product
 Table 49. Alexion Revenue in Soliris (Eculizumab) Business (US$ Million), 2021–2026
 Table 50. Alexion Recent Development
 Table 51. Research Programs/Design for This Report
 Table 52. Key Data Information from Secondary Sources
 Table 53. Key Data Information from Primary Sources
 Table 54. Authors List of This Report


List of Figures
 Figure 1. Soliris (Eculizumab) Picture
 Figure 2. Global Soliris (Eculizumab) Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Soliris (Eculizumab) Market Share by Type: 2025 vs 2032
 Figure 4. Plasma Exchange Features
 Figure 5. Plasma Infusion Features
 Figure 6. Global Soliris (Eculizumab) Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Soliris (Eculizumab) Market Share by Application: 2025 vs 2032
 Figure 8. PNH Case Studies
 Figure 9. aHUS Case Studies
 Figure 10. Others Case Studies
 Figure 11. Soliris (Eculizumab) Report Years Considered
 Figure 12. Global Soliris (Eculizumab) Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Soliris (Eculizumab) Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Soliris (Eculizumab) Market Share by Region: 2025 vs 2032
 Figure 15. Global Soliris (Eculizumab) Market Share by Players in 2025
 Figure 16. Global Soliris (Eculizumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Soliris (Eculizumab) Revenue in 2025
 Figure 18. North America Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Soliris (Eculizumab) Market Share by Country (2021–2032)
 Figure 20. United States Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Soliris (Eculizumab) Market Share by Country (2021–2032)
 Figure 24. Germany Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Soliris (Eculizumab) Market Share by Region (2021–2032)
 Figure 32. China Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Soliris (Eculizumab) Market Share by Country (2021–2032)
 Figure 40. Mexico Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Soliris (Eculizumab) Market Share by Country (2021–2032)
 Figure 44. Israel Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Soliris (Eculizumab) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Alexion Revenue Growth Rate in Soliris (Eculizumab) Business (2021–2026)
 Figure 48. Bottom-up and Top-down Approaches for This Report
 Figure 49. Data Triangulation
 Figure 50. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Soliris Market Insights Forecast to 2030
Soliris Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Satralizumab Market Research Report 2025
Global Siltuximab Market Research Report 2024
Global Atezolizumab Market Research Report 2024
Tocilizumab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global EPIRBs Market Research Report 2024
Global Filgrastim and Biosimilars Market Research Report 2024
Global Elotuzumab Market Research Report 2024
Global Burosumab Market Research Report 2025
Biosimilar Drug Market
Global Biosimilar and Biologics Market Research Report 2024
Global Cetuximab Biosimilar Market Research Report 2025
Global Belimumab Market Research Report 2024
Global Axitinib Market Research Report 2025
Global Nicosulfuron Market Research Report 2025
Global Nesiritide Market Research Report 2024
Global Trametinib Market Research Report 2025
Global Ramucirumab Market Research Report 2024
Global Tislelizumab Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions